CENCORA, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 224.6 USD | +0.23% |
|
+0.29% | +9.36% |
| May. 08 | Jefferies Adjusts Price Target on Cencora to $230 From $235 | MT |
| May. 03 | Wells Fargo Adjusts Cencora Price Target to $236 From $235 | MT |
ETFs positioned on Cencora, Inc.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 0 M€ | +2.80% | - | |
| 0.01% | 0 M€ | +0.32% | - | |
| 0.01% | 0 M€ | +0.50% | - | |
| 0.01% | 0 M€ | +3.95% | - | |
| 0.00% | 0 M€ | +1.95% | - | |
| 2.06% | 0 M€ | +6.50% | - |
Cencora, Inc. specializes in distributing pharmaceutical products. The group supplies generic and name-brand medications, OTC healthcare products, and home care equipment to healthcare providers (hospitals, clinics, pharmacies, physicians, etc.) located in the United States and Canada. The group also offers services to physicians and patients (support and reimbursement assistance services, prescription management services, nursing services, home injection and perfusion services, etc.).
Calendar
2024-07-30
- Q3 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
224.6
USD
Average target price
254.5
USD
Spread / Average Target
+13.30%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +9.36% | 44.8B | |
| -4.84% | 182B | |
| +0.56% | 110B | |
| -3.35% | 68.11B | |
| +2.39% | 50.53B | |
| +2.70% | 40.7B | |
| +24.51% | 32.3B | |
| +3.43% | 26.53B | |
| -0.32% | 24.96B | |
| +13.67% | 25.02B |
- Stock Market
- Equities
- COR Stock
- Funds and ETFs Cencora, Inc.
